STOCK TITAN

Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, has scheduled the release of its second quarter 2025 financial results for Wednesday, August 6th, 2025. The company will host a conference call at 8:30 A.M. (EST) to discuss the results.

Perrigo is a pure-play self-care company specializing in over-the-counter (OTC) health and wellness solutions in North America and Europe. Their business model combines store brand private label offerings with leading brands including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+2.07% News Effect

On the day this news was published, PRGO gained 2.07%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, July 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2025 financial results on Wednesday, August 6th, 2025, and host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 45051. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, August 6, until midnight Wednesday, August 13, 2025. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 45051#.

About Perrigo

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

For more information, visit www.perrigo.com.

Forward-Looking Statements 

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-second-quarter-2025-financial-results-on-august-6-2025-302511250.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (PRGO) release Q2 2025 earnings?

Perrigo will release its second quarter 2025 financial results on Wednesday, August 6th, 2025 at 8:30 A.M. (EST).

How can investors access Perrigo's Q2 2025 earnings call?

Investors can access the call via webcast at perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184 (International: 646-357-8785) using ID #45051.

What are Perrigo's main consumer brands?

Perrigo's leading brands include Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

When will the replay of Perrigo's Q2 2025 earnings call be available?

The replay will be available from 12:00 P.M. (EST) August 6 until midnight August 13, 2025. To access, dial 888-660-6345 (International: 646-517-4150) with access code 45051#.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

1.91B
137.01M
0.41%
105.88%
5.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2